Guggenheim Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-336,377
Closed -$33.4M 2242
2019
Q3
$33.4M Sell
336,377
-33,837
-9% -$3.22M 0.27% 67
2019
Q2
$34.2M Sell
370,214
-31,034
-8% -$2.95M 0.28% 58
2019
Q1
$37.9M Buy
401,248
+34
+0% +$2.97K 0.31% 50
2018
Q4
$25.7M Sell
401,214
-41,496
-9% -$3.06M 0.22% 68
2018
Q3
$39.6M Sell
442,710
-25,266
-5% -$2.23M 0.26% 48
2018
Q2
$37.2M Sell
467,976
-640,566
-58% -$53.2M 0.25% 48
2018
Q1
$98.9M Buy
1,108,542
+60,773
+6% +$5.83M 0.24% 46
2017
Q4
$109M Buy
1,047,769
+19,218
+2% +$2.17M 0.26% 36
2017
Q3
$150M Sell
1,028,551
-102,338
-9% -$13.9M 0.35% 12
2017
Q2
$147M Buy
1,130,889
+74,730
+7% +$9.16M 0.39% 6
2017
Q1
$131M Sell
1,056,159
-41,232
-4% -$4.93M 0.36% 7
2016
Q4
$127M Buy
1,097,391
+37,967
+4% +$4.23M 0.36% 9
2016
Q3
$111M Buy
1,059,424
+81,974
+8% +$8.87M 0.34% 17
2016
Q2
$96.4M Sell
977,450
-52,385
-5% -$5.42M 0.3% 28
2016
Q1
$103M Sell
1,029,835
-179,643
-15% -$18.5M 0.33% 19
2015
Q4
$145M Sell
1,209,478
-114,084
-9% -$13.2M 0.42% 8
2015
Q3
$143M Sell
1,323,562
-202,707
-13% -$25.2M 0.44% 10
2015
Q2
$177M Buy
1,526,269
+133,824
+10% +$15.3M 0.44% 10
2015
Q1
$161M Buy
1,392,445
+207,733
+18% +$24.8M 0.38% 10
2014
Q4
$133M Sell
1,184,712
-69,317
-6% -$7.31M 0.33% 13
2014
Q3
$119M Buy
1,254,029
+80,569
+7% +$7.27M 0.28% 23
2014
Q2
$101M Sell
1,173,460
-77,344
-6% -$5.88M 0.26% 28
2014
Q1
$87.3M Sell
1,250,804
-187,170
-13% -$14.8M 0.25% 40
2013
Q4
$121M Buy
1,437,974
+253,038
+21% +$20M 0.37% 11
2013
Q3
$91.2M Sell
1,184,936
-16,800
-1% -$1.18M 0.33% 22
2013
Q2
$70.2M Buy
+1,201,736
New +$72.3M 0.3% 26

Other funds holding CELG

Guggenheim Capital's CELG Position: Q4 2019 in Review

Guggenheim Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 336,377 shares — an estimated $33.4M sold.

Guggenheim Capital first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $177M in Q2 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Guggenheim Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Guggenheim Capital sold 336,377 Celgene Corp shares in Q4 2019, an estimated $33.4M.
  • Guggenheim Capital first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Guggenheim Capital's Celgene Corp position peaked at $177M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Guggenheim Capital's 13F filing for Q4 2019, filed 14 Feb 2020.